Low Social Well-Being in Advanced and Metastatic Prostate Cancer: Effects of a Randomized Controlled Trial of Cognitive Behavioral Stress Management

Overview

Journal Int J Behav Med

Publisher Informa Healthcare

Date 2024 Feb 21

PMID 38378974

Authors

Rui Gong

Aaron Heller

Patricia I Moreno

Betina Yanez

Frank J Penedo

Affiliations

Soon will be listed here.

Abstract

Background: Social well-being impacts cancer patients' health-related quality of life (HRQOL) and coping style. This secondary analysis was conducted to examine whether advanced prostate cancer survivors who had experienced low social well-being would benefit from a web-based cognitive behavioral stress management (CBSM) intervention.

Method: APC survivors (N = 192) who had received androgen deprivation therapy (ADT) were randomized to a 10-week CBSM or a health promotion (HP) control condition. A subsample of participants (n = 61) with low pre-intervention SWB (measured by social support from and relationship satisfaction with family and friends) was included in the study. Multilevel models compared participants' PC-specific quality of life (sexual, hormonal, urinary), affect-based psychosocial burden (cancer-related anxiety and distress), and coping strategies at baseline, 6 months, and 12 months. Covariates were included in all models as appropriate.

Results: Participants randomized to the CBSM condition showed significantly greater improvements in fear of cancer recurrence and cancer-related intrusive thoughts than those in the HP control condition. A significant condition by time interaction was also found, indicating that CBSM improved participants' PC-related fear in both short- (6 months) and long-term (12 months). However, the CBSM intervention did not significantly impact APC-related symptom burden. Only for the urinary domain, clinically meaningful changes (CBSM vs HP) were observed. In addition, all participants, regardless of condition, reported less coping (e.g., emotion-, problem- and avoidance-focused) over time.

Conclusion: As predicted, the CBSM intervention improved several affect-based psychosocial outcomes for APC survivors with low baseline SWB.

References

Leung J, Pachana N, McLaughlin D . Social support and health-related quality of life in women with breast cancer: a longitudinal study. Psychooncology. 2014; 23(9):1014-20. DOI: 10.1002/pon.3523. View

Guan T, Judge Santacroce S, Chen D, Song L . Illness uncertainty, coping, and quality of life among patients with prostate cancer. Psychooncology. 2020; 29(6):1019-1025. PMC: 7440775. DOI: 10.1002/pon.5372. View

Penedo F, Fox R, Oswald L, Moreno P, Boland C, Estabrook R . Technology-Based Psychosocial Intervention to Improve Quality of Life and Reduce Symptom Burden in Men with Advanced Prostate Cancer: Results from a Randomized Controlled Trial. Int J Behav Med. 2020; 27(5):490-505. PMC: 7587609. DOI: 10.1007/s12529-019-09839-7. View

Yildirim Usta Y . Importance of social support in cancer patients. Asian Pac J Cancer Prev. 2012; 13(8):3569-72. DOI: 10.7314/apjcp.2012.13.8.3569. View

Skolarus T, Dunn R, Sanda M, Chang P, Greenfield T, Litwin M . Minimally important difference for the Expanded Prostate Cancer Index Composite Short Form. Urology. 2014; 85(1):101-5. PMC: 4274392. DOI: 10.1016/j.urology.2014.08.044. View

Wright-St Clair V, Malcolm W, Keogh J . The lived experience of physically active older prostate cancer survivors on androgen deprivation therapy. Aging Male. 2013; 17(1):57-62. DOI: 10.3109/13685538.2013.818113. View

Rhee H, Gunter J, Heathcote P, Ho K, Stricker P, Corcoran N . Adverse effects of androgen-deprivation therapy in prostate cancer and their management. BJU Int. 2014; 115 Suppl 5:3-13. DOI: 10.1111/bju.12964. View

Carver C, Scheier M, Weintraub J . Assessing coping strategies: a theoretically based approach. J Pers Soc Psychol. 1989; 56(2):267-83. DOI: 10.1037//0022-3514.56.2.267. View

Pearman T, Yanez B, Peipert J, Wortman K, Beaumont J, Cella D . Ambulatory cancer and US general population reference values and cutoff scores for the functional assessment of cancer therapy. Cancer. 2014; 120(18):2902-9. DOI: 10.1002/cncr.28758. View

10.

Donovan K, Walker L, Wassersug R, Thompson L, Robinson J . Psychological effects of androgen-deprivation therapy on men with prostate cancer and their partners. Cancer. 2015; 121(24):4286-99. DOI: 10.1002/cncr.29672. View

11.

Say R, Murtagh M, Thomson R . Patients' preference for involvement in medical decision making: a narrative review. Patient Educ Couns. 2006; 60(2):102-14. DOI: 10.1016/j.pec.2005.02.003. View

12.

Moreno P, Stanton A . Personal growth during the experience of advanced cancer: a systematic review. Cancer J. 2013; 19(5):421-30. DOI: 10.1097/PPO.0b013e3182a5bbe7. View

13.

Boen C, Barrow D, Bensen J, Farnan L, Gerstel A, Hendrix L . Social Relationships, Inflammation, and Cancer Survival. Cancer Epidemiol Biomarkers Prev. 2018; 27(5):541-549. PMC: 5932225. DOI: 10.1158/1055-9965.EPI-17-0836. View

14.

Penedo F, Molton I, Dahn J, Shen B, Kinsinger D, Traeger L . A randomized clinical trial of group-based cognitive-behavioral stress management in localized prostate cancer: development of stress management skills improves quality of life and benefit finding. Ann Behav Med. 2006; 31(3):261-70. DOI: 10.1207/s15324796abm3103_8. View

15.

Jayadevappa R, Malkowicz S, Wittink M, Wein A, Chhatre S . Comparison of distribution- and anchor-based approaches to infer changes in health-related quality of life of prostate cancer survivors. Health Serv Res. 2012; 47(5):1902-25. PMC: 3513611. DOI: 10.1111/j.1475-6773.2012.01395.x. View

16.

Beacon H, Thompson S . Multi-level models for repeated measurement data: application to quality of life data in clinical trials. Stat Med. 1996; 15(24):2717-32. DOI: 10.1002/(SICI)1097-0258(19961230)15:24<2717::AID-SIM518>3.0.CO;2-E. View

17.

Kadambi S, Soto-Perez-de-Celis E, Garg T, Loh K, Krok-Schoen J, Battisti N . Social support for older adults with cancer: Young International Society of Geriatric Oncology review paper. J Geriatr Oncol. 2019; 11(2):217-224. PMC: 7384244. DOI: 10.1016/j.jgo.2019.09.005. View

18.

Pinquart M, Duberstein P . Associations of social networks with cancer mortality: a meta-analysis. Crit Rev Oncol Hematol. 2009; 75(2):122-37. PMC: 2910231. DOI: 10.1016/j.critrevonc.2009.06.003. View

19.

Siegel R, Miller K, Fuchs H, Jemal A . Cancer statistics, 2022. CA Cancer J Clin. 2022; 72(1):7-33. DOI: 10.3322/caac.21708. View

20.

Aggarwal V, Montoya C, Donnenberg V, Sant S . Interplay between tumor microenvironment and partial EMT as the driver of tumor progression. iScience. 2021; 24(2):102113. PMC: 7892926. DOI: 10.1016/j.isci.2021.102113. View